A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fc Receptors To Define the Role of Effector Functions in Protection against HIV
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fc Receptors To Define the Role of Effector Functions in Protection against HIV
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 85, Issue 20, Pages 10572-10581
Publisher
American Society for Microbiology
Online
2011-08-18
DOI
10.1128/jvi.05541-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity
- (2010) Joshua S Klein et al. AIDS
- Therapeutic Antibodies in HIV Treatment - Classical Approaches to Novel Advances
- (2010) Irene A. Abela et al. CURRENT PHARMACEUTICAL DESIGN
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Fc-Glycosylation Influences Fc Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12
- (2010) D. N. Forthal et al. JOURNAL OF IMMUNOLOGY
- HIV-1 Replication in Langerhans and Interstitial Dendritic Cells Is Inhibited by Neutralizing and Fc-Mediated Inhibitory Antibodies
- (2010) M. Peressin et al. JOURNAL OF VIROLOGY
- In-Solution Virus Capture Assay Helps Deconstruct Heterogeneous Antibody Recognition of Human Immunodeficiency Virus Type 1
- (2010) D. P. Leaman et al. JOURNAL OF VIROLOGY
- Antibodies to watch in 2010
- (2010) Janice M. Reichert mAbs
- CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody
- (2009) F. T. Awan et al. BLOOD
- A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
- (2009) Pina M. Cardarelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41
- (2009) L. G. Perez et al. JOURNAL OF VIROLOGY
- Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
- (2009) Ann J Hessell et al. NATURE MEDICINE
- Glycosylation as a strategy to improve antibody-based therapeutics
- (2009) Roy Jefferis NATURE REVIEWS DRUG DISCOVERY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fc receptor-mediated antiviral antibodies
- (2009) Donald N Forthal et al. Current Opinion in HIV and AIDS
- The Cat and Mouse of HIV-1 Antibody Escape
- (2009) John R. Mascola PLoS Pathogens
- Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
- (2009) Ann J. Hessell et al. PLoS Pathogens
- Optimization of antibody binding to Fc RIIa enhances macrophage phagocytosis of tumor cells
- (2008) J. O. Richards et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now